1. Home
  2. CC vs TMDX Comparison

CC vs TMDX Comparison

Compare CC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemours Company (The)

CC

Chemours Company (The)

HOLD

Current Price

$22.12

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$66.78

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CC
TMDX
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
2.2B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
CC
TMDX
Price
$22.12
$66.78
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$20.11
$148.22
AVG Volume (30 Days)
3.0M
1.8M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.20
Revenue
$6,638,000,000.00
$605,494,000.00
Revenue This Year
$6.15
$24.25
Revenue Next Year
$5.95
$18.75
P/E Ratio
N/A
$341.18
Revenue Growth
7.36
37.13
52 Week Low
$9.13
$60.11
52 Week High
$28.67
$156.00

Technical Indicators

Market Signals
Indicator
CC
TMDX
Relative Strength Index (RSI) 44.68 31.32
Support Level $20.47 $60.11
Resistance Level $25.69 $120.60
Average True Range (ATR) 1.12 3.81
MACD -0.26 1.43
Stochastic Oscillator 32.64 61.30

Price Performance

Historical Comparison
CC
TMDX

About CC Chemours Company (The)

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: